Abstract:The Gram-negative, opportunistic pathogen Pseudomonas aeruginosa has become a serious threat to global health, with increasing resistance towards even the most potent antibiotics. Like other bacteria, the pathogen produces a number of virulence factors that promote its pathogenicity. Of these, metallophores constitute an important group, able to scavenge metal ions from the surrounding environment to secure the metabolic functions of the bacterium. Pseudomonads produce the iron-chelating metallophore (siderophore) pyochelin (PCH), which, in addition to its iron scavenging ability, is an effector for the transcriptional regulator PchR in its Feᴵᴵᴵ-bound form (ferripyochelin). In the present study, docking studies predicted a major ferripyochelin binding site in PchR, which prompted the exploration of nor-pyochelin analogs to produce tight binding to PchR, and thereby establish a lasting effector response associated with upregulation of the genes involved in the PCH metabolism. In addition, we investigated the effects of using the analogs to bind the antimicrobial cations Gaᴵᴵᴵ and Inᴵᴵᴵ, leading to enhanced uptake and further disruption of the cell machinery. Selected analogs of nor-pyochelin (nor-PCH) were synthesized and their Gaᴵᴵᴵ and Inᴵᴵᴵ-based complexes were assessed for antimicrobial activity. The results indicate that the Gaᴵᴵᴵ-complexes inhibit the pathogens under iron-limited conditions, while the Inᴵᴵᴵ-based systems are more effective in iron-rich media. Several of the Gaᴵᴵᴵ-complexes were shown to be highly effective against an MDR P. aeruginosa clinical isolate, with minimum inhibitory concentrations (MICs) of ≤1 µg/mL. Similarly, two of the Inᴵᴵᴵ-based systems were particularly effective against the isolate, with an MIC of 8 µg/mL. These results show high promise in comparison with other, traditionally potent antibiotics. Preliminary mechanistic investigations of the antimicrobial activity using pseudomonal transposon mutants suggested that the inhibitory effects of the Inᴵᴵᴵ-based systems could be due to acute iron deficiency as a result of Inᴵᴵᴵ-bound bacterioferritin (BfrB). Cytotoxiticy analysis indicated that the compounds generally show low toxicity toward mammalian cells under the experimental conditions.

Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth

Activity of Neutrophils Infected by Chlamydia Trachomatis is Modulated by Kang Fuyan Capsule

Bioactivity of pyocyanin of Pseudomonas aeruginosa clinical isolates against a variety of human pathogenic bacteria and fungi species

"Production, characterization and biomedical application of pyocyanin pigment produced by competent Pseudomonas species"

Effects of pyocyanine, a blue pigment from Pseudomonas aeruginosa, on separate steps of T cell activation: interleukin 2 (IL 2) production, IL 2 receptor formation, proliferation and induction of cytolytic activity

The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular Chlamydia and Wolbachia and Break the Persistence Phenotype in Chlamydia

Antifungal potential of multi-drug-resistant Pseudomonas aeruginosa: harnessing pyocyanin for candida growth inhibition

A biomedical perspective of pyocyanin from Pseudomonas aeruginosa: its applications and challenges

Acylpyrazoline-Based Third-Generation Selective Antichlamydial Compounds with Enhanced Potency

The Chlamydia psittaci Inclusion Membrane Protein 0556 Inhibits Human Neutrophils Apoptosis Through PI3K/AKT and NF-κB Signaling Pathways

Effects of nuclear factor kappa B inhibitor pyrrolidine dithiocarbamate on the expression of pro- and anti-inflammatory cytokines in mice with Chlamydia pneumoniae pneumonia

Chlamydia Persistence: A Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo

Nafamostat mesylate inhibits chlamydial intracellular growth in cell culture and reduces chlamydial infection in the mouse genital tract

Efficacy of a Novel Affitoxin Targeting Major Outer Membrane Protein Against Chlamydia Trachomatis in Vitro and in Vivo

The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35

Chlamydomonas reinhardtii -derived Mytichitin-CB/Hispidalin Chimera Efficiently Inhibits the Growth of Bacteria by Disrupting Their Membrane Integrity

Antimicrobial Potency of Nor-Pyochelin Analogs and Their Cation Complexes Against Multidrug-Resistant Pathogens

Isolation, Identification and Characterization of Phytoplankton-Lytic Bacterium Ch-22 Against Microcystis Aeruginosa

Suppression of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments

A Cyclic Dipeptide from Marine Fungus Penicillium chrysogenum DXY-1 Exhibits Anti-quorum Sensing Activity

Efficacy of a novel affitoxin targeting MOMP against Chlamydia trachomatis in vitro and in vivo